Autoimmune CD4 + T cells Cause Meibomian Gland Dysfunction

Read full text
Authors: Kaitlin K. Scholand, Paola A. Guevara Montoya, Emre Aksan, Yangluowa Qu, Sean Paiboonfungfuang, Laura Schaefer, Elizaveta A. Demianova, Elaine T. Vo, Sudhir Verma, Elle Joy J San Juan, Zhiyuan Yu, Tarsis F. Gesteira
+2 more Vivien Jane Coulson‐Thomas, Cintia Sade de Paiva
Cited by: 0
References: 80

Abstract

Abstract Sjögren disease (SjD) is an autoimmune disease driven by autoreactive CD4 + T cells that leads to an immune-mediated loss of lacrimal glands. Meibomian glands are lipid-producing glands in the eyelids that help prevent tear evaporation. While the role of T cells in lacrimal gland-mediated destruction is well established, it is unknown whether pathogenic T cells can cause MG dysfunction (MGD). Herein, we investigated whether autoreactive CD4 + T cells induce MGD and characterized the pathophysiologic mechanisms using an adoptive transfer model. T cells were isolated from CD25KO (CD4 KO ) or wild-type (CD4 WT ) mice, transferred into Rag1 KO mice. Further, CD4 KO cells were co-adoptively transferred with WT regulatory T cells (CD4 KO +Tregs WT ). Our results demonstrate that CD4 KO recipients had MG dropout, CD4 + IFN-γ + infiltration, increased MHC II presentation within the periglandular area, MG fibrosis, and decreased lipid production and upregulation of pathways related to inflammation, including Type II interferon signaling. Rag1 KO, CD4 WT , and CD4 KO +Tregs WT recipients exhibited minimal inflammation in the periglandular MG area. These results indicate that autoimmune CD4 + T cells are sufficient to cause MGD, and healthy young regulatory T cells can prevent T-cell-mediated damage. Taken together, our findings provide mechanistic insights into the pathogenesis autoimmune SjD, and could impact how patients are managed in the clinic.

Fields of Study & Subjects

Ocular Surface and Contact Lens Salivary Gland Disorders and Functions Otitis Media and Relapsing Polychondritis

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publication date
9 January 2026
Language
EN
Document type
Preprint